Cookie Policy

We use cookies on our website and have placed these on your computer. By continuing to use our website you consent to this. For more information, including how to change your cookie settings and to disable our non-essential Google Analytics cookies, please refer to our Cookie Policy. If you do not wish to be reminded of this on each visit, please use the close button.

Newsround: Volatility returns as Bank of England points to higher rates

9 February 2018


Tags: Macro Economics

 FTSE News

After significant volatility in global markets earlier in the week the FTSE 100 was under pressure again on Thursday as the Bank of England hinted at an increase in interest rates sooner than expected. By the close the index of leading UK shares was down 1.5% at 7,170.69.

Inflation figures for the UK and the US are set to be released on Tuesday (13 February) and Wednesday (14 February) respectively next week (see Economic update). Also on Wednesday, monthly US retail sales figures are published. This is a significant announcement as it is the primary gauge of consumer spending, which accounts for most of overall economic activity in the world’s largest economy. The UK’s own retail sales data is out on Friday, followed later by the US building permits release. This offers an excellent insight into future construction activity as obtaining a permit is one of the first steps in constructing a new building.

Sector in Focus

While the wider market correction has hogged the spotlight, there was also the small matter of fourth quarter and full year results from the UK’s two biggest oil companies for the market to digest. Of the UK’s two large integrated oil companies, BP (BP.) looks to be the winner over Royal Dutch Shell (RDSB) in terms of fourth quarter and full year results. Shares in both companies fell on the day of their results earlier this month but BP’s performance both in share price terms and operationally was the more impressive, with a modest fall in its shares on 6 February coming amid a much wider market decline. Expectations for both sets of results were high after a significant recovery in the oil price.

Shell’s largely in-line numbers, reported on 1 February, were not enough to match these expectations. Current cost of supply earnings (Shell’s preferred measure of profit) excluding one-off items came in at $15.76 billion for 2017 compared with $7.19 billion a year earlier. However, this was only marginally ahead of the analyst consensus figure of $15.72 billion. In part this was due to a weaker than expected performance from its downstream (refining and marketing) operations. This pattern was repeated in the quarterly results from US rivals ExxonMobil and Chevron. BP posted underlying replacement cost profit of $2.1 billion for the fourth quarter against consensus estimates for $1.9 billion, quadrupling year-on-year, and, in contrast, delivered ‘very strong’ downstream earnings.

Economic Update

The beginning of February has seen a significant market correction which began in the US and then spread to stock markets around the world. Most observers attributed the weakness to expectations for acceleration in US interest rate hikes as the Federal Reserve contends with mounting inflationary pressures. Investors will get some insight into just how acute these pressures are when the latest readings of UK and US inflation are released on Tuesday (13 February) and Wednesday (14 February) respectively next week.

ETF Watch

Gold is often sought out as a safe haven at times of market volatility. Exposure to the precious metal can be achieved through exchange-traded fund iShares Global Gold (SGLN) which has an ongoing charge of 0.25%.

Company Announcements

14 February - Management will be looking to draw a clear line between their charge and liquidated construction services business Carillion (CLLN) when Galliford Try (GFRD) reports its half year results. Since Carillion’s collapse on 15 January, Galliford Try’s shares have fallen significantly in value, with the group warning of a potential £30 million to £40 million cash outflow to complete a joint venture it was working on with Carillion.

15 February - Supply issues and a fall in full year revenue growth toppled ConvaTec’s (CTEC) shares late last year, leaving the wound care specialist trading below the 225p price at which it joined the stock market in October 2016. Management need to spell out when ConvaTec supply problems in its advanced wound and ostomy care division can be resolved.

Writer: Tom Sieber Tags: Macro Economics

You can start investing today through any of our account options:

Dealing Account

Access a wide range of global investments in this flexible, unrestricted account.

Find out more

Stocks and Shares ISA

Take advantage of tax free investing with our Stocks and Shares ISA today.

Find out more

Self-Invested Personal Pension (SIPP)

From great value to best-in-class, access the SIPP to suit your needs through our extensive network of providers.

Find out more

I've still got questions!

We’re on hand to help at our Customer Experience Centre on 0345 0700 720

Selftrade does not provide investment advice. This article is the authors view and is not the view or opinion of Selftrade and Selftrade accepts no liability for any loss caused as a result of the use of this information. The opinions expressed are those of the author at the time of writing and should not be interpreted as investment advice.

The value of investments can fall as well as rise and any income from them is not guaranteed and you may get back less than you invested. Past performance is not a guide to future performance. We do not provide advice or make recommendations about investments. If you have any doubts about the suitability of an investment, you should seek advice from a suitably qualified professional adviser.

If you have a Stocks and Shares ISA, make sure you get the best value for your investments. We are ranked top for price on large portfolios (Platforum, 2018).

Open an account today and we’ll cover any transfer fees up to £100.*

*T&Cs apply.

Open a Stocks & Shares ISA

Find out more